Carl Zeiss Meditec AG (ETR:AFX - Get Free Report)'s share price dropped 0.1% during mid-day trading on Monday . The stock traded as low as €53.75 ($56.58) and last traded at €54.85 ($57.74). Approximately 241,302 shares traded hands during mid-day trading, an increase of 156% from the average daily volume of 94,405 shares. The stock had previously closed at €54.90 ($57.79).
Carl Zeiss Meditec Stock Up 0.5 %
The firm has a fifty day simple moving average of €50.77 and a 200-day simple moving average of €57.50. The company has a market capitalization of $5.12 billion, a P/E ratio of 29.37, a P/E/G ratio of 2.83 and a beta of 0.98. The company has a quick ratio of 2.47, a current ratio of 2.13 and a debt-to-equity ratio of 7.41.
About Carl Zeiss Meditec
(
Get Free Report)
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Recommended Stories
Before you consider Carl Zeiss Meditec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Carl Zeiss Meditec wasn't on the list.
While Carl Zeiss Meditec currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
